Page 111 - Read Online

Dewsbury et al. J Transl Genet Genom 2024;8:85-101 https://dx.doi.org/10.20517/jtgg.2023.58 Page 97

2. Sheth J, Nair A. Treatment for lysosomal storage disorders. Curr Pharm Des 2020;26:5110-8. DOI PubMed
3. Platt FM, Boland B, van der Spoel AC. The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal
dysfunction. J Cell Biol 2012;199:723-34. DOI PubMed PMC
4. Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA 1999;281:249-54. DOI PubMed
5. Malm D, Nilssen Ø. Alpha-mannosidosis. Orphanet J Rare Dis 2008;3:21. DOI PubMed PMC
6. Riise Stensland HM, Frantzen G, Kuokkanen E, et al. amamutdb.no: a relational database for MAN2B1 allelic variants that compiles
genotypes, clinical phenotypes, and biochemical and structural data of mutant MAN2B1 in α-mannosidosis. Hum Mutat 2015;36:581-
6. DOI
7. Stepien KM, Roncaroli F, Turton N, et al. Mechanisms of mitochondrial dysfunction in lysosomal storage disorders: a review. J Clin
Med 2020;9:2596. DOI PubMed PMC
8. Borgwardt L, Stensland HM, Olsen KJ, et al. Alpha-mannosidosis: correlation between phenotype, genotype and mutant MAN2B1
subcellular localisation. Orphanet J Rare Dis 2015;10:70. DOI PubMed PMC
9. Stepien KM, Cufflin N, Donald A, Jones S, Church H, Hargreaves IP. Secondary mitochondrial dysfunction as a cause of
neurodegenerative dysfunction in lysosomal storage diseases and an overview of potential therapies. Int J Mol Sci 2022;23:10573.
DOI PubMed PMC
10. Guffon N, Tylki-Szymanska A, Borgwardt L, et al. Recognition of alpha-mannosidosis in paediatric and adult patients: presentation
of a diagnostic algorithm from an international working group. Mol Genet Metab 2019;126:470-4. DOI
11. Jakubczyk K, Dec K, Kałduńska J, Kawczuga D, Kochman J, Janda K. Reactive oxygen species - sources, functions, oxidative
damage. Pol Merkur Lekarski 2020;48:124-7. PubMed
12. Tan EY, Boelens JJ, Jones SA, Wynn RF. Hematopoietic stem cell transplantation in inborn errors of metabolism. Front Pediatr
2019;7:433. DOI PubMed PMC
13. Adam J, Malone R, Lloyd S, Lee J, Hendriksz CJ, Ramaswami U. Disease progression of alpha-mannosidosis and impact on patients
and carers - a UK natural history survey. Mol Genet Metab Rep 2019;20:100480. DOI PubMed PMC
14. Edelmann MJ, Maegawa GHB. CNS-targeting therapies for lysosomal storage diseases: current advances and challenges. Front Mol
Biosci 2020;7:559804. DOI PubMed PMC
15. Dietemann JL, Filippi de la Palavesa MM, Tranchant C, Kastler B. MR findings in mannosidosis. Neuroradiology 1990;32:485-7.
DOI PubMed
16. Lipiński P, Różdżyńska-Świątkowska A, Iwanicka-Pronicka K, Perkowska B, Pokora P, Tylki-Szymańska A. Long-term outcome of
patients with alpha-mannosidosis - a single center study. Mol Genet Metab Rep 2022;30:100826. DOI PubMed PMC
17. Borgwardt L, Thuesen AM, Olsen KJ, Fogh J, Dali CI, Lund AM. Cognitive profile and activities of daily living: 35 patients with
alpha-mannosidosis. J Inherit Metab Dis 2015;38:1119-27. DOI PubMed
18. Hafiz S, De Jesus O. Ataxia. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from: https://www.ncbi.nlm.
nih.gov/books/NBK562284/ [Last accessed on 13 Mar 2024].
19. Kawai H, Nishino H, Nishida Y, et al. Skeletal muscle pathology of mannosidosis in two siblings with spastic paraplegia. Acta
Neuropathol 1985;68:201-4. DOI
20. Carpenter S, Karpati G. Lysosomal storage in human skeletal muscle. Hum Pathol 1986;17:683-703. DOI PubMed
21. Autio S, Louhimo T, Helenius M. The clinical course of mannosidosis. Ann Clin Res 1982;14:93-7. PubMed
22. Yunis JJ, Lewandowski RC Jr, Sanfilippo SJ, Tsai MY, Foni I, Bruhl HH. Clinical manifestations of mannosidosis - a longitudinal
study. Am J Med 1976;61:841-8. DOI PubMed
23. Bach G, Kohn G, Lasch EE, et al. A new variant of mannosidosis with increased residual enzymatic activity and mild clinical
manifestation. Pediatr Res 1978;12:1010-5. DOI
24. Cathey SS, Sarasua SM, Simensen R, et al. Intellectual functioning in alpha-mannosidosis. JIMD Rep 2019;50:44-9. DOI PubMed
PMC
25. Sedel F, Baumann N, Turpin JC, Lyon-Caen O, Saudubray JM, Cohen D. Psychiatric manifestations revealing inborn errors of
metabolism in adolescents and adults. J Inherit Metab Dis 2007;30:631-41. DOI PubMed
26. Danielsen ER, Lund AM, Thomsen C. Cerebral magnetic resonance spectroscopy demonstrates long-term effect of bone marrow
transplantation in α-mannosidosis. In: Zschocke J, Gibson KM, Brown G, Morava E, Peters V, editors. JIMD reports - volume 11.
Berlin: Springer Berlin Heidelberg; 2013. pp. 49-52. DOI PubMed PMC
27. Gutschalk A, Harting I, Cantz M, Springer C, Rohrschneider K, Meinck HM. Adult alpha-mannosidosis: clinical progression in the
absence of demyelination. Neurology 2004;63:1744-6. DOI PubMed
28. Malm D, Pantel J, Linaker OM. Psychiatric symptoms in alpha-mannosidosis. J Intellect Disabil Res 2005;49:865-71. DOI PubMed
29. Ara JR, Mayayo E, Marzo ME, et al. Neurological impairment in alpha-mannosidosis: a longitudinal clinical and MRI study of a
brother and sister. Childs Nerv Syst 1999;15:369-71. DOI
30. Majovska J, Nestrasil I, Paulson A, et al. White matter alteration and cerebellar atrophy are hallmarks of brain MRI in alpha-
mannosidosis. Mol Genet Metab 2021;132:189-97. DOI
31. Malaquias MJ, Pinto E, Oliveira J, Freixo JP, Caseiro C, Magalhães M. Alpha-mannosidosis: a novel cause of bilateral thalami and
dentate nuclei hyperintensity. Can J Neurol Sci 2022;49:704-5. DOI PubMed
32. Borgwardt L, Danielsen ER, Thomsen C, et al. Alpha-mannosidosis: characterization of CNS pathology and correlation between CNS
pathology and cognitive function. Clin Genet 2016;89:489-94. DOI